[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

SI1384477T1 - Utilization of pyrazoline derivatives in the preparation of a medicament for the prevention and/or treatment of proliferative cell diseases - Google Patents

Utilization of pyrazoline derivatives in the preparation of a medicament for the prevention and/or treatment of proliferative cell diseases

Info

Publication number
SI1384477T1
SI1384477T1 SI200230345T SI200230345T SI1384477T1 SI 1384477 T1 SI1384477 T1 SI 1384477T1 SI 200230345 T SI200230345 T SI 200230345T SI 200230345 T SI200230345 T SI 200230345T SI 1384477 T1 SI1384477 T1 SI 1384477T1
Authority
SI
Slovenia
Prior art keywords
medicament
utilization
prevention
preparation
treatment
Prior art date
Application number
SI200230345T
Other languages
Slovenian (sl)
Inventor
Maria Rosa Cuberes-Altisent
Juana Maria Berrocal-Romero
Maria Montser Contijoch-Llobet
Jordi Frigola-Constansa
Original Assignee
Esteve Labor Dr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from ES200100818A external-priority patent/ES2174757B1/en
Application filed by Esteve Labor Dr filed Critical Esteve Labor Dr
Publication of SI1384477T1 publication Critical patent/SI1384477T1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/06—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
SI200230345T 2001-04-06 2002-03-21 Utilization of pyrazoline derivatives in the preparation of a medicament for the prevention and/or treatment of proliferative cell diseases SI1384477T1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ES200100818A ES2174757B1 (en) 2001-04-06 2001-04-06 EMPLOYMENT OF FIRAZOLIN DERIVATIVES IN THE PREPARATION OF A MEDICINAL PRODUCT FOR THE PREVENTION AND / OR TREATMENT OF CELLULAR PROLIFERATIVE DISEASES.
EP02714233A EP1384477B1 (en) 2001-04-06 2002-03-21 Utilization of pyrazoline derivatives in the preparation of a medicament for the prevention and/or treatment of proliferative cell diseases
PCT/ES2002/000137 WO2002080909A1 (en) 2001-04-06 2002-03-21 Utilization of pyrazoline derivatives in the preparation of a medicament for the prevention and/or treatment of proliferative cell diseases

Publications (1)

Publication Number Publication Date
SI1384477T1 true SI1384477T1 (en) 2006-08-31

Family

ID=34196126

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200230345T SI1384477T1 (en) 2001-04-06 2002-03-21 Utilization of pyrazoline derivatives in the preparation of a medicament for the prevention and/or treatment of proliferative cell diseases

Country Status (1)

Country Link
SI (1) SI1384477T1 (en)

Similar Documents

Publication Publication Date Title
AU2002246152A1 (en) Utilization of pyrazoline derivatives in the preparation of a medicament for the prevention and/or treatment of proliferative cell diseases
HUP0400918A3 (en) Utilization of pyrazoline derivatives in the preparation of pharmaceutical compositions for the prevention and/or treatment of proliferative cell diseases
HK1089376A1 (en) Formulation for use in the prevention and treatment of carbohydrate induced ; diseases and conditions
AU2002213357A1 (en) Variant igg3 rituxan r and therapeutic use thereof
HUP0401461A3 (en) Phenylsulfonyl-1,3-dihydro-2h-indole-2-one derivatives, their preparation and their therapeutic use
HRP20010655B1 (en) Pyridopyranoazepine derivatives, preparation and therapeutic use
HUP0301333A3 (en) Pharmaceutical superdisintegrant, process for its preparation and its use
HRP20041157B1 (en) Piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof
TWI318974B (en) Acylaminothiazole derivatives, their preparation and their therapeutic use
PT1525193E (en) Acylaminothiazole derivatives, preparation and therapeutic use thereof
AU2003232148A1 (en) A selective inos inhibitor and a pde inhibitor in combination for the treatment of respiratory diseases
IL155853A0 (en) Substituted cyclohexane derivatives and the use thereof in medicaments for treating cardiovascular diseases
IL165612A0 (en) Novel arylimidazole derivatives preparation and therapeutic uses thereof
AU2003244455A1 (en) Piperidylcarboxamide derivatives and their use in the treatment of tachykinim-mediated diseases
HK1074444A1 (en) Acyloxypyrrolidine derivatives, preparation and therapeutic use thereof
SI1384477T1 (en) Utilization of pyrazoline derivatives in the preparation of a medicament for the prevention and/or treatment of proliferative cell diseases
AU2002311141A1 (en) The use of hydrochloric acid in the preparation of a medicament for the treatment of tumour
HK1065792A1 (en) 3-Heteroaryl-3,5-dihydro-4-oxo-4H-pyridazino Ä4,5-BÜindole-1-carboxamide derivatives, their preparation and therapeutic use
IL148924A (en) Use of agents that inhibit the activity of intracellular elastase in the preparation of a medicament for treating and/or preventing necrosis of cells and diseases associated therewith
AU2908501A (en) Combination therapy for the treatment of inflammatory and respiratory diseases
IL149653A0 (en) 2-arylquinoline derivatives, preparation and therapeutic use thereof
IL165420A0 (en) Piperazinylacylpiperidine derivatives their preparation and therapeutic use thereof
AU2003230818A1 (en) PrLZ REGULATORY ELEMENTS IN THE TREATMENT OF DISEASE AND THE DISCOVERY OF THERAPEUTICS
GB0130733D0 (en) Therapeutic compounds and their use in therapy
AU2728301A (en) Combination therapy for the treatment of inflammatory and respiratory diseases